Piramal Pharma Limited has informed the Exchange regarding a press release dated January 28, 2026, titled "Piramal Pharma Limited Announces Results for Q3 and 9M FY26".
Piramal Pharma Limited Press Release Jan 29 2026
Filed with NSE ·
6ix hasn’t read this filing yet.
In the deck
Earlier from Piramal Pharma
- Piramal Pharma Achieves Notable Score Increase on 2025 S&P Global Corporate Sustainability Assessment (CSA)
- Piramal Pharma Solutions Demonstrates Commitment to Excellence with Outstanding Net Promoter Score
- Piramal Pharma Solutions Achieves Regulatory Compliance for Nitrosamine Impurities
- Piramal Pharma Solutions' Bioconjugates Facility in Grangemouth, UK Receives Updated MHRA GMP Certificates
- Press Release Nov 05 2025
Later from Piramal Pharma
- Piramal Pharma Limited Announces Results for Q3 and 9M FY26
- Piramal Pharma Solutions Introduces Tablet-in-Capsule Capabilities
- Press Release Feb 05 2026
- Piramal Critical Care and Blue-Zone Technologies collaborate to capture, collect and recycle waste anaesthesia gas
- Piramal Pharma Solutions' Grangemouth, UK Facility Successfully Delivers 1,500th ADC Batch
Follow Piramal Pharma into a list and get an email when it puts out news.
Follow Piramal Pharma